loader2
Partner With Us NRI

Jubilant Ingrevia Ltd share Price Today

Company details

575.40
595.00
399.00
604.70
6M Return 20.72%
1Y Return 44.53%
Mkt Cap.(Cr) 9,349.00
Volume 674,314
Div Yield 0.85%
OI
-
OI Chg %
-
Volume 674,314

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Speciality Chemicals company Jubilant Ingrevia announced Q1FY25 results:

  • Total Revenue: Rs 1,024 crore

    • Change QoQ: Decreased by 5%
    • Change YoY: Decreased by 5%
  • Total EBITDA: Rs 119 crore

    • Change QoQ: Increased by 18%
    • Change YoY: Decreased by 5%
  • EBITDA Margin: 12

  • Profit After Tax: Rs 49 crore

    • Change QoQ: Increased by 67%
    • Change YoY: Decreased by 15%
  • Profit After Tax Margin: 5%

  • Basic and Diluted EPS (Rs.): Rs 3.1

    • Change QoQ: Increased by 67%
    • Change YoY: Decreased by 15%
  • The capex for the quarter was Rs 116 crore, which was primarily funded through internal accruals
  • Net Working Capital ‘Percentage to Turnover’ for Q1FY25 was lower at 18.6% as against 20% in Q1FY24
  • Reduced Number of days of Working capital to 68, as against 73 in Q1FY24

Shyam S Bhartia Chairman & Hari S Bhartia Co-Chairman, said: "We reaffirm our expectation of witnessing improvements in all three business segments in FY25 over FY24. Like last quarter, our key focus remains customer-centricity, ramping up the newly commissioned plants, remaining lean and bringing back the margins to normal levels.

We are focused towards keeping the costs in control through our Project Lean and are on track to source renewable energy for our long-term energy requirements, which also underscores our firm commitment towards sustainability & environment.

We continue to see increasing utilisation of our newly created plants, and we remain on track with our capex plans towards investing in high-potential product categories to deliver on our bold vision of Pinnacle 345 i.e. 3 times Revenue, 4 times EBIDTA, in 5 years.”

Result PDF

View Other Company Results

Jubilant Ingrevia Ltd shares SWOT Analysis

Strengths (6)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt

Weakness (9)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 596.2
R2 605.4
R3 615.8
Pivot

585.78

S1 576.6
S2 566.2
S3 557.0
EMA SMA
555.1
533.8
515.4
495.6
549.8
527.5
509.3
483.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-07-09 585.56 1137543 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2024-07-09 586.11 1137543 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-04-10 536.5 954343 NSE
Name Category Shares
PRIYAVRAT BHARTIA PROMOTER 0.88%
SPB TRUSTEE COMPANY PL & SS TRUSTEE COMPANY PL PROMOTER 20.63%
HSB TRUSTEE COMPANY PL & HS TRUSTEE COMPANY PL PROMOTER 19%
MILLER HOLDINGS PTE LTD PROMOTER 3.53%
MAV MANAGEMENT ADVISORS LLP PROMOTER 3.15%
NIKITA RESOURCES PRIVATE LIMITED PROMOTER 2.2%
JUBILANT ENPRO PRIVATE LIMITED PROMOTER 1.77%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Jubilant Ingrevia Ltd Stocks COMPARISON

Financials( in Cr) Jubilant Ingrevia Ltd Pidilite Industries Ltd Linde India Ltd SRF Ltd Deepak Nitrite Ltd
Price 586.95 3,175.15 8,617.50 2,394.60 2,799.10
% Change 1.15 0.43 -0.73 -0.22 2.72
Mcap Cr 9,349.00 161,490.99 73,493.49 70,981.93 38,177.76
Revenue TTM Cr 4,772.69 12,382.99 3,135.52 13,138.52 7,681.83
Net Profit TTM Cr 307.50 1,747.42 538.06 1,335.71 810.89
PE TTM 53.67 90.58 169.26 53.27 50.64
1 Year Return 44.53 22.32 100.10 9.45 40.88
ROCE 15.59 29.30 16.29 12.52 21.56
ROE 12.06 22.37 14.70 12.25 16.38
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 2,666.24 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 100,072.29 51,097.20
LAST 6M 183,053.48 43,859.44
LAST 12M 309,832.68 84,987.81
Jubilant Ingrevia Limited - Press Release

Jul 16, 2024 l NSE Announcement

Board Meetings Forthcomming

Jul 16, 2024 l Board Meetings Forthcomming

NSE Board Meetings Forthcomming

Jul 16, 2024 l NSE Board Meetings Forthcomming

Date Action Type Ratio
Aug 02, 2024 Dividend 250
Feb 09, 2024 Dividend 250
Aug 10, 2023 Dividend 250

Jubilant Ingrevia Ltd Information

Stock PE (TTM)
53.67
Promoter Holding
51.47%
Book Value
171.8721
ROCE
15.59%
ROE
12.06%
Description
  • Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on 23 October 2019 in Uttar Pradesh. The name of Company was changed from `Jubilant LSI Limited` to `Jubilant Ingrevia Limited` effective October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges - Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited. The Company`s state-of-the-art manufacturing facilities across India offer a range of products and solutions that are innovative, cost effective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scale-up and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition & health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. The business focuses on three core segments - Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and India`s largest manufacturer of Vitamin B4. The Company is a `Partner of Choice` for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand `Phytoshield`. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date. During FY 2022-23, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.

Registered Address

Bhartiagram, Gajraula, Amroha, Uttar Pradesh, 244223

Tel : 91-120-4361000
Email : deepanjali.gulati:jubl.com
Website : http://www.jubilantingrevia.com
Registrar

Alankit Assignments Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 543271
NSE Code : JUBLINGREA
Book Closure Date (Month) :
BSE Group : A
ISIN : INE0BY001018

FAQ’s on Jubilant Ingrevia Ltd Shares

You can buy Jubilant Ingrevia Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jubilant Ingrevia Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 04:08 PM the closing price of Jubilant Ingrevia Ltd was Rs.586.95.

The latest PE ratio of Jubilant Ingrevia Ltd as of Jul 16, 2024 04:08 PM is 53.67

The latest PB ratio of Jubilant Ingrevia Ltd as of Jul 16, 2024 04:08 PM is 0.29

The 52-week high of Jubilant Ingrevia Ltd share price is Rs. 604.70 while the 52-week low is Rs. 399.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 04:08 PM, the market cap of Jubilant Ingrevia Ltd stood at Rs. 9,349.00 Cr.

Download App

Download Our App

Play Store App Store
market app